FDA approves third oncology drug that targets a key genetic driver of cancer, rather than a specific type of tumor - FDA Press Releases

FDA approves third cancer treatment based on a common biomarker across different types of tumors rather than the location in the body where the tumor originated

from FDA Press Releases RSS Feed https://ift.tt/31QU0hB
via IFTTT